
Westlake Chemical Partners LP | 10-Q: FY2025 Q3 Revenue: USD 308.9 M

I'm PortAI, I can summarize articles.
Revenue: As of FY2025 Q3, the actual value is USD 308.9 M.
EPS: As of FY2025 Q3, the actual value is USD 0.42.
EBIT: As of FY2025 Q3, the actual value is USD 97.7 M.
Segment Revenue
- Net Sales - Westlake: $276.5 million for the three months ended September 30, 2025, compared to $215.8 million for the same period in 2024. For the nine months ended September 30, 2025, net sales were $736.4 million compared to $690.5 million in 2024.
- Net Co-products, Ethylene and Other Sales - Third Parties: $32.4 million for the three months ended September 30, 2025, compared to $61.2 million for the same period in 2024. For the nine months ended September 30, 2025, sales were $107.3 million compared to $155.3 million in 2024.
Operational Metrics
- Gross Profit: $99.4 million for the three months ended September 30, 2025, compared to $116.9 million for the same period in 2024. For the nine months ended September 30, 2025, gross profit was $251.0 million compared to $320.4 million in 2024.
- Income from Operations: $92.0 million for the three months ended September 30, 2025, compared to $109.7 million for the same period in 2024. For the nine months ended September 30, 2025, income from operations was $229.8 million compared to $298.4 million in 2024.
- Net Income: $86.2 million for the three months ended September 30, 2025, compared to $104.1 million for the same period in 2024. For the nine months ended September 30, 2025, net income was $214.3 million compared to $281.8 million in 2024.
Cash Flow
- Net Cash Provided by Operating Activities: $160.1 million for the nine months ended September 30, 2025, compared to $352.5 million for the same period in 2024.
- Net Cash Used for Financing Activities: $230.5 million for the nine months ended September 30, 2025, compared to $300.4 million for the same period in 2024.
Unique Metrics
- MLP Distributable Cash Flow: $14.9 million for the three months ended September 30, 2025, compared to $17.9 million for the same period in 2024. For the nine months ended September 30, 2025, MLP distributable cash flow was $34.6 million compared to $51.9 million in 2024.
- EBITDA: $126.1 million for the three months ended September 30, 2025, compared to $139.1 million for the same period in 2024. For the nine months ended September 30, 2025, EBITDA was $325.5 million compared to $386.8 million in 2024.
Future Outlook and Strategy
- Core Business Focus: The company has renewed the Ethylene Sales Agreement and the Feedstock Supply Agreement through December 31, 2027, which includes automatic 12-month renewal periods. This renewal aligns with the Services and Secondment Agreement and the Omnibus Agreement, ensuring continuity in operations and strategic alignment with Westlake.
- Non-Core Business: No specific plans related to divestitures or emerging segments were mentioned in the report.

